BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 10502 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(F)c2)n1 InChI=1S/C18H18FN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) CEOOKKDARWYWCG-UHFFFAOYSA-N 6388 3-[(5-{6-[(3-fluorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-[[5-[6-[(3-Fluorophenyl)amino]pyrazinyl]-3-pyridinyl]-amino]-1-propanol::Pyrazine-Pyridine Biheteroaryl 11 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6388&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330359 8035980 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10503 COc1cccc(Nc2cncc(n2)-c2cncc(NCCCO)c2)c1 InChI=1S/C19H21N5O2/c1-26-17-5-2-4-15(9-17)23-19-13-21-12-18(24-19)14-8-16(11-20-10-14)22-6-3-7-25/h2,4-5,8-13,22,25H,3,6-7H2,1H3,(H,23,24) TYOTYOPLSRQPGK-UHFFFAOYSA-N 6389 3-[[5-[6-[(3-Methoxyphenyl)amino]pyrazinyl]-3-pyridinyl]-1-propanol::3-[(5-{6-[(3-methoxyphenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 15 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6389 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6389&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330360 8035981 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10504 OCCCNc1cncc(c1)-c1cncc(Nc2ccccc2Cl)n1 InChI=1S/C18H18ClN5O/c19-15-4-1-2-5-16(15)23-18-12-21-11-17(24-18)13-8-14(10-20-9-13)22-6-3-7-25/h1-2,4-5,8-12,22,25H,3,6-7H2,(H,23,24) OQNHOXSUGWCWDP-UHFFFAOYSA-N 6390 3-{5-[6-(2-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::3-[(5-{6-[(2-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 19 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6390&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330361 8035982 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10505 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-4-1-5-20(12-19)29-23-16-27-15-22(30-23)18-11-21(14-26-13-18)28-8-2-3-17-6-9-25-10-7-17/h1,4-7,9-16,28H,2-3,8H2,(H,29,30) WYCDDSZFBQZASO-UHFFFAOYSA-N 6391 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 20 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6391&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330362 8035983 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10506 Clc1ccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)cc1 InChI=1S/C23H21ClN6/c24-19-3-5-20(6-4-19)29-23-16-27-15-22(30-23)18-12-21(14-26-13-18)28-9-1-2-17-7-10-25-11-8-17/h3-8,10-16,28H,1-2,9H2,(H,29,30) YKNBMORIVLLGGL-UHFFFAOYSA-N 6392 (4-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)pyridin-3-yl]-pyrazin-2-yl}-amine::N-(4-chlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 24 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6392&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330363 8035984 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10507 Clc1ccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)cc1Cl InChI=1S/C23H20Cl2N6/c24-20-4-3-18(11-21(20)25)30-23-15-28-14-22(31-23)17-10-19(13-27-12-17)29-7-1-2-16-5-8-26-9-6-16/h3-6,8-15,29H,1-2,7H2,(H,30,31) WDJAMFCUZITORN-UHFFFAOYSA-N 6393 N-(3,4-dichlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3,4-Dichloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 28 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6393&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330364 8035985 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10508 OCCCNc1cncc(c1)-c1cncc(NCc2ccccc2)n1 InChI=1S/C19H21N5O/c25-8-4-7-22-17-9-16(11-20-12-17)18-13-21-14-19(24-18)23-10-15-5-2-1-3-6-15/h1-3,5-6,9,11-14,22,25H,4,7-8,10H2,(H,23,24) DTEFNUQVFFTDEE-UHFFFAOYSA-N 6394 3-[5-(6-Benzylamino-pyrazin-2-yl)-pyridin-3-yl-amino]-propan-1-ol::3-({5-[6-(benzylamino)pyrazin-2-yl]pyridin-3-yl}amino)propan-1-ol::Pyrazine-Pyridine Biheteroaryl 32 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6394&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330365 8035986 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10509 OCCCNc1cncc(c1)-c1cncc(Oc2cccc(Cl)c2)n1 InChI=1S/C18H17ClN4O2/c19-14-3-1-4-16(8-14)25-18-12-21-11-17(23-18)13-7-15(10-20-9-13)22-5-2-6-24/h1,3-4,7-12,22,24H,2,5-6H2 GGTQQIDOJIMFSO-UHFFFAOYSA-N 6395 3-({5-[6-(3-chlorophenoxy)pyrazin-2-yl]pyridin-3-yl}amino)propan-1-ol::3-{5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-pyridin-3-yl-amino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 36 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6395&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330366 8035987 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10510 Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C15H12ClN5/c16-11-2-1-3-13(5-11)20-15-9-19-8-14(21-15)10-4-12(17)7-18-6-10/h1-9H,17H2,(H,20,21) DJAHLZXHKVPSHL-UHFFFAOYSA-N 6396 [6-(5-Amino-pyridin-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-amine::6-(5-aminopyridin-3-yl)-N-(3-chlorophenyl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 37 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6396&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330367 8035988 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10511 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(F)c2)n1 InChI=1S/C18H18FN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) CEOOKKDARWYWCG-UHFFFAOYSA-N 6388 3-[(5-{6-[(3-fluorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-[[5-[6-[(3-Fluorophenyl)amino]pyrazinyl]-3-pyridinyl]-amino]-1-propanol::Pyrazine-Pyridine Biheteroaryl 11 Vascular endothelial growth factor receptor 2 Rattus norvegicus 168 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6388&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330359 8035980 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10512 COc1cccc(Nc2cncc(n2)-c2cncc(NCCCO)c2)c1 InChI=1S/C19H21N5O2/c1-26-17-5-2-4-15(9-17)23-19-13-21-12-18(24-19)14-8-16(11-20-10-14)22-6-3-7-25/h2,4-5,8-13,22,25H,3,6-7H2,1H3,(H,23,24) TYOTYOPLSRQPGK-UHFFFAOYSA-N 6389 3-[[5-[6-[(3-Methoxyphenyl)amino]pyrazinyl]-3-pyridinyl]-1-propanol::3-[(5-{6-[(3-methoxyphenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 15 Vascular endothelial growth factor receptor 2 Rattus norvegicus 740 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6389 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6389&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330360 8035981 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10513 OCCCNc1cncc(c1)-c1cncc(Nc2ccccc2Cl)n1 InChI=1S/C18H18ClN5O/c19-15-4-1-2-5-16(15)23-18-12-21-11-17(24-18)13-8-14(10-20-9-13)22-6-3-7-25/h1-2,4-5,8-12,22,25H,3,6-7H2,(H,23,24) OQNHOXSUGWCWDP-UHFFFAOYSA-N 6390 3-{5-[6-(2-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::3-[(5-{6-[(2-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 19 Vascular endothelial growth factor receptor 2 Rattus norvegicus 1010 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6390&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330361 8035982 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10514 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-4-1-5-20(12-19)29-23-16-27-15-22(30-23)18-11-21(14-26-13-18)28-8-2-3-17-6-9-25-10-7-17/h1,4-7,9-16,28H,2-3,8H2,(H,29,30) WYCDDSZFBQZASO-UHFFFAOYSA-N 6391 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 20 Vascular endothelial growth factor receptor 2 Rattus norvegicus 76 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6391&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330362 8035983 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10515 Clc1ccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)cc1 InChI=1S/C23H21ClN6/c24-19-3-5-20(6-4-19)29-23-16-27-15-22(30-23)18-12-21(14-26-13-18)28-9-1-2-17-7-10-25-11-8-17/h3-8,10-16,28H,1-2,9H2,(H,29,30) YKNBMORIVLLGGL-UHFFFAOYSA-N 6392 (4-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)pyridin-3-yl]-pyrazin-2-yl}-amine::N-(4-chlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 24 Vascular endothelial growth factor receptor 2 Rattus norvegicus 1000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6392&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330363 8035984 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10516 Clc1ccc(Nc2cncc(n2)-c2cncc(NCCCc3ccncc3)c2)cc1Cl InChI=1S/C23H20Cl2N6/c24-20-4-3-18(11-21(20)25)30-23-15-28-14-22(31-23)17-10-19(13-27-12-17)29-7-1-2-16-5-8-26-9-6-16/h3-6,8-15,29H,1-2,7H2,(H,30,31) WDJAMFCUZITORN-UHFFFAOYSA-N 6393 N-(3,4-dichlorophenyl)-6-(5-{[3-(pyridin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3,4-Dichloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 28 Vascular endothelial growth factor receptor 2 Rattus norvegicus 189 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6393&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330364 8035985 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10517 OCCCNc1cncc(c1)-c1cncc(NCc2ccccc2)n1 InChI=1S/C19H21N5O/c25-8-4-7-22-17-9-16(11-20-12-17)18-13-21-14-19(24-18)23-10-15-5-2-1-3-6-15/h1-3,5-6,9,11-14,22,25H,4,7-8,10H2,(H,23,24) DTEFNUQVFFTDEE-UHFFFAOYSA-N 6394 3-[5-(6-Benzylamino-pyrazin-2-yl)-pyridin-3-yl-amino]-propan-1-ol::3-({5-[6-(benzylamino)pyrazin-2-yl]pyridin-3-yl}amino)propan-1-ol::Pyrazine-Pyridine Biheteroaryl 32 Vascular endothelial growth factor receptor 2 Rattus norvegicus 1050 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6394&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330365 8035986 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10518 OCCCNc1cncc(c1)-c1cncc(Oc2cccc(Cl)c2)n1 InChI=1S/C18H17ClN4O2/c19-14-3-1-4-16(8-14)25-18-12-21-11-17(23-18)13-7-15(10-20-9-13)22-5-2-6-24/h1,3-4,7-12,22,24H,2,5-6H2 GGTQQIDOJIMFSO-UHFFFAOYSA-N 6395 3-({5-[6-(3-chlorophenoxy)pyrazin-2-yl]pyridin-3-yl}amino)propan-1-ol::3-{5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-pyridin-3-yl-amino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 36 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6395&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330366 8035987 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10519 Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C15H12ClN5/c16-11-2-1-3-13(5-11)20-15-9-19-8-14(21-15)10-4-12(17)7-18-6-10/h1-9H,17H2,(H,20,21) DJAHLZXHKVPSHL-UHFFFAOYSA-N 6396 [6-(5-Amino-pyridin-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-amine::6-(5-aminopyridin-3-yl)-N-(3-chlorophenyl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 37 Vascular endothelial growth factor receptor 2 Rattus norvegicus 1160 8.0000 30.00 C Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6396&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330367 8035988 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10520 OCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C17H16ClN5O/c18-13-2-1-3-14(7-13)22-17-11-20-10-16(23-17)12-6-15(9-19-8-12)21-4-5-24/h1-3,6-11,21,24H,4-5H2,(H,22,23) NDENTZARMCMWHO-UHFFFAOYSA-N 6397 2-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-ethanol::2-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]ethan-1-ol::Pyrazine-Pyridine Biheteroaryl 38 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6397&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330368 8035989 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10521 CN(C)CCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C20H23ClN6/c1-27(2)8-4-7-24-18-9-15(11-22-12-18)19-13-23-14-20(26-19)25-17-6-3-5-16(21)10-17/h3,5-6,9-14,24H,4,7-8H2,1-2H3,(H,25,26) SEYTYFBRYYSXAY-UHFFFAOYSA-N 6398 N-(3-chlorophenyl)-6-(5-{[3-(dimethylamino)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-propane-1,3-diamine::Pyrazine-Pyridine Biheteroaryl 40 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6398&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330369 8035990 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10522 CN(C)CCNC(=O)c1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C20H21ClN6O/c1-27(2)7-6-24-20(28)15-8-14(10-22-11-15)18-12-23-13-19(26-18)25-17-5-3-4-16(21)9-17/h3-5,8-13H,6-7H2,1-2H3,(H,24,28)(H,25,26) JOOCYOYATLAZKH-UHFFFAOYSA-N 6399 5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-N-[2-(dimethylamino)ethyl]pyridine-3-carboxamide::5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-N-(2-(dimethylamino)-ethyl)-nicotinamide::Pyrazine-Pyridine Biheteroaryl 42 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens 3690 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6399&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330370 8035991 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10523 OCCCNC(=O)c1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c20-15-3-1-4-16(8-15)24-18-12-22-11-17(25-18)13-7-14(10-21-9-13)19(27)23-5-2-6-26/h1,3-4,7-12,26H,2,5-6H2,(H,23,27)(H,24,25) CQKZPPUFUROCPO-UHFFFAOYSA-N 6400 5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-N-(3-hydroxy-propyl)-nicotinamide::5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-N-(3-hydroxypropyl)pyridine-3-carboxamide::Pyrazine-Pyridine Biheteroaryl 43 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6400&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330371 8035992 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10524 OCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C17H14ClN5O2/c18-12-2-1-3-13(5-12)21-16-9-20-8-15(23-16)11-4-14(7-19-6-11)22-17(25)10-24/h1-9,24H,10H2,(H,21,23)(H,22,25) LMHRDOSOBKKYLF-UHFFFAOYSA-N 6401 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-hydroxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-hydroxyacetamide::Pyrazine-Pyridine Biheteroaryl 44 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6401 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6401&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330372 8035993 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10525 COCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H16ClN5O2/c1-26-11-18(25)23-15-5-12(7-20-8-15)16-9-21-10-17(24-16)22-14-4-2-3-13(19)6-14/h2-10H,11H2,1H3,(H,22,24)(H,23,25) JJEKRZADDFLKDS-UHFFFAOYSA-N 6402 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-methoxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-methoxyacetamide::Pyrazine-Pyridine Biheteroaryl 45 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6402 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6402&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330373 8035994 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10526 COCCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c1-27-6-5-19(26)24-16-7-13(9-21-10-16)17-11-22-12-18(25-17)23-15-4-2-3-14(20)8-15/h2-4,7-12H,5-6H2,1H3,(H,23,25)(H,24,26) FJUNBZBUUOJZKU-UHFFFAOYSA-N 6403 N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-3-methoxypropanamide::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-3-methoxy-propionamide::Pyrazine-Pyridine Biheteroaryl 46 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6403&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330374 8035995 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10527 Clc1cccc(Nc2cncc(n2)-c2cncc(NC(=O)COCc3ccccc3)c2)c1 InChI=1S/C24H20ClN5O2/c25-19-7-4-8-20(10-19)28-23-14-27-13-22(30-23)18-9-21(12-26-11-18)29-24(31)16-32-15-17-5-2-1-3-6-17/h1-14H,15-16H2,(H,28,30)(H,29,31) VNWIFJVTNVMBLJ-UHFFFAOYSA-N 6404 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-benzyloxy-acetamide::2-(benzyloxy)-N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)acetamide::Pyrazine-Pyridine Biheteroaryl 47 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6404&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330375 8035996 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10528 Clc1cccc(Nc2cncc(n2)-c2cncc(NC(=O)COc3ccccc3)c2)c1 InChI=1S/C23H18ClN5O2/c24-17-5-4-6-18(10-17)27-22-14-26-13-21(29-22)16-9-19(12-25-11-16)28-23(30)15-31-20-7-2-1-3-8-20/h1-14H,15H2,(H,27,29)(H,28,30) KMBNVVBGWONPFT-UHFFFAOYSA-N 6405 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-phenoxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-phenoxyacetamide::Pyrazine-Pyridine Biheteroaryl 48 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6405&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330376 8035997 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10529 CN(C)c1ccc(cc1)C(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C24H21ClN6O/c1-31(2)21-8-6-16(7-9-21)24(32)29-20-10-17(12-26-13-20)22-14-27-15-23(30-22)28-19-5-3-4-18(25)11-19/h3-15H,1-2H3,(H,28,30)(H,29,32) MKQUABVRXBYMTD-UHFFFAOYSA-N 6406 N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-4-(dimethylamino)benzamide::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-4-(dimethylamino)-benzamide::Pyrazine-Pyridine Biheteroaryl 49 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6406&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330377 8035998 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10530 OCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C17H16ClN5O/c18-13-2-1-3-14(7-13)22-17-11-20-10-16(23-17)12-6-15(9-19-8-12)21-4-5-24/h1-3,6-11,21,24H,4-5H2,(H,22,23) NDENTZARMCMWHO-UHFFFAOYSA-N 6397 2-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-ethanol::2-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]ethan-1-ol::Pyrazine-Pyridine Biheteroaryl 38 Vascular endothelial growth factor receptor 2 Rattus norvegicus 275 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6397&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330368 8035989 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10531 CN(C)CCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C20H23ClN6/c1-27(2)8-4-7-24-18-9-15(11-22-12-18)19-13-23-14-20(26-19)25-17-6-3-5-16(21)10-17/h3,5-6,9-14,24H,4,7-8H2,1-2H3,(H,25,26) SEYTYFBRYYSXAY-UHFFFAOYSA-N 6398 N-(3-chlorophenyl)-6-(5-{[3-(dimethylamino)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-propane-1,3-diamine::Pyrazine-Pyridine Biheteroaryl 40 Vascular endothelial growth factor receptor 2 Rattus norvegicus 135 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6398&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330369 8035990 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10532 CN(C)CCNC(=O)c1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C20H21ClN6O/c1-27(2)7-6-24-20(28)15-8-14(10-22-11-15)18-12-23-13-19(26-18)25-17-5-3-4-16(21)9-17/h3-5,8-13H,6-7H2,1-2H3,(H,24,28)(H,25,26) JOOCYOYATLAZKH-UHFFFAOYSA-N 6399 5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-N-[2-(dimethylamino)ethyl]pyridine-3-carboxamide::5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-N-(2-(dimethylamino)-ethyl)-nicotinamide::Pyrazine-Pyridine Biheteroaryl 42 Vascular endothelial growth factor receptor 2 Rattus norvegicus 4300 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6399&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330370 8035991 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10533 OCCCNC(=O)c1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c20-15-3-1-4-16(8-15)24-18-12-22-11-17(25-18)13-7-14(10-21-9-13)19(27)23-5-2-6-26/h1,3-4,7-12,26H,2,5-6H2,(H,23,27)(H,24,25) CQKZPPUFUROCPO-UHFFFAOYSA-N 6400 5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-N-(3-hydroxy-propyl)-nicotinamide::5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-N-(3-hydroxypropyl)pyridine-3-carboxamide::Pyrazine-Pyridine Biheteroaryl 43 Vascular endothelial growth factor receptor 2 Rattus norvegicus 2380 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6400&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330371 8035992 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10534 OCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C17H14ClN5O2/c18-12-2-1-3-13(5-12)21-16-9-20-8-15(23-16)11-4-14(7-19-6-11)22-17(25)10-24/h1-9,24H,10H2,(H,21,23)(H,22,25) LMHRDOSOBKKYLF-UHFFFAOYSA-N 6401 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-hydroxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-hydroxyacetamide::Pyrazine-Pyridine Biheteroaryl 44 Vascular endothelial growth factor receptor 2 Rattus norvegicus 346 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6401 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6401&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330372 8035993 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10535 COCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H16ClN5O2/c1-26-11-18(25)23-15-5-12(7-20-8-15)16-9-21-10-17(24-16)22-14-4-2-3-13(19)6-14/h2-10H,11H2,1H3,(H,22,24)(H,23,25) JJEKRZADDFLKDS-UHFFFAOYSA-N 6402 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-methoxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-methoxyacetamide::Pyrazine-Pyridine Biheteroaryl 45 Vascular endothelial growth factor receptor 2 Rattus norvegicus 303 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6402 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6402&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330373 8035994 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10536 COCCC(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c1-27-6-5-19(26)24-16-7-13(9-21-10-16)17-11-22-12-18(25-17)23-15-4-2-3-14(20)8-15/h2-4,7-12H,5-6H2,1H3,(H,23,25)(H,24,26) FJUNBZBUUOJZKU-UHFFFAOYSA-N 6403 N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-3-methoxypropanamide::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-3-methoxy-propionamide::Pyrazine-Pyridine Biheteroaryl 46 Vascular endothelial growth factor receptor 2 Rattus norvegicus 593 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6403&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330374 8035995 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10537 Clc1cccc(Nc2cncc(n2)-c2cncc(NC(=O)COCc3ccccc3)c2)c1 InChI=1S/C24H20ClN5O2/c25-19-7-4-8-20(10-19)28-23-14-27-13-22(30-23)18-9-21(12-26-11-18)29-24(31)16-32-15-17-5-2-1-3-6-17/h1-14H,15-16H2,(H,28,30)(H,29,31) VNWIFJVTNVMBLJ-UHFFFAOYSA-N 6404 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-benzyloxy-acetamide::2-(benzyloxy)-N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)acetamide::Pyrazine-Pyridine Biheteroaryl 47 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6404&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330375 8035996 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10538 Clc1cccc(Nc2cncc(n2)-c2cncc(NC(=O)COc3ccccc3)c2)c1 InChI=1S/C23H18ClN5O2/c24-17-5-4-6-18(10-17)27-22-14-26-13-21(29-22)16-9-19(12-25-11-16)28-23(30)15-31-20-7-2-1-3-8-20/h1-14H,15H2,(H,27,29)(H,28,30) KMBNVVBGWONPFT-UHFFFAOYSA-N 6405 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-phenoxy-acetamide::N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-2-phenoxyacetamide::Pyrazine-Pyridine Biheteroaryl 48 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6405&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330376 8035997 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10539 CN(C)c1ccc(cc1)C(=O)Nc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C24H21ClN6O/c1-31(2)21-8-6-16(7-9-21)24(32)29-20-10-17(12-26-13-20)22-14-27-15-23(30-22)28-19-5-3-4-18(25)11-19/h3-15H,1-2H3,(H,28,30)(H,29,32) MKQUABVRXBYMTD-UHFFFAOYSA-N 6406 N-(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)-4-(dimethylamino)benzamide::N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-4-(dimethylamino)-benzamide::Pyrazine-Pyridine Biheteroaryl 49 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6406&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330377 8035998 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10540 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCNCC3)c2)c1 InChI=1S/C22H26ClN7/c23-18-3-1-4-19(12-18)28-22-16-26-15-21(29-22)17-11-20(14-25-13-17)27-5-2-8-30-9-6-24-7-10-30/h1,3-4,11-16,24,27H,2,5-10H2,(H,28,29) DERTUZZNGDWMOY-UHFFFAOYSA-N 6407 N-(3-Chlorophenyl)-6-[5-[[3-(1-piperazinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(piperazin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 50 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens 5615 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6407 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6407&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330378 8035999 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10541 CN1CCN(CCCNc2cncc(c2)-c2cncc(Nc3cccc(Cl)c3)n2)CC1 InChI=1S/C23H28ClN7/c1-30-8-10-31(11-9-30)7-3-6-27-21-12-18(14-25-15-21)22-16-26-17-23(29-22)28-20-5-2-4-19(24)13-20/h2,4-5,12-17,27H,3,6-11H2,1H3,(H,28,29) MRWZXJLKVRBEII-UHFFFAOYSA-N 6408 N-(3-chlorophenyl)-6-(5-{[3-(4-methylpiperazin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3-Chlorophenyl)-(6-{5-[3-(4-methyl-piperazin-1-yl)-propylamino]-pyridin-3-yl}-pyrazin-2-yl)-amine::Pyrazine-Pyridine Biheteroaryl 51 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6408&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330379 8036000 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10542 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCOCC3)c2)c1 InChI=1S/C22H25ClN6O/c23-18-3-1-4-19(12-18)27-22-16-25-15-21(28-22)17-11-20(14-24-13-17)26-5-2-6-29-7-9-30-10-8-29/h1,3-4,11-16,26H,2,5-10H2,(H,27,28) ILIYEHQBHWMGTJ-UHFFFAOYSA-N 6409 N-[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]-4-morpholinepropanamine::N-(3-chlorophenyl)-6-(5-{[3-(morpholin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 52 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6409&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330380 8036001 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10543 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCCCC3)c2)c1 InChI=1S/C23H27ClN6/c24-19-6-4-7-20(13-19)28-23-17-26-16-22(29-23)18-12-21(15-25-14-18)27-8-5-11-30-9-2-1-3-10-30/h4,6-7,12-17,27H,1-3,5,8-11H2,(H,28,29) SQOMHHDPYUXRBG-UHFFFAOYSA-N 6410 (3-Chlorophenyl)-{6-[5-(3-piperidin-1-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::N-(3-chlorophenyl)-6-(5-{[3-(piperidin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 53 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens 5385 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6410 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6410&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330381 8036002 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10544 Clc1cccc(Nc2cncc(n2)-c2cncc(NCC3CCOCC3)c2)c1 InChI=1S/C21H22ClN5O/c22-17-2-1-3-18(9-17)26-21-14-24-13-20(27-21)16-8-19(12-23-11-16)25-10-15-4-6-28-7-5-15/h1-3,8-9,11-15,25H,4-7,10H2,(H,26,27) ALEMXOWDMCVYMB-UHFFFAOYSA-N 6411 N-(3-chlorophenyl)-6-{5-[(oxan-4-ylmethyl)amino]pyridin-3-yl}pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[(tetrahydro-2H-pyran-4-yl)-methyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 54 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6411&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330382 8036003 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10545 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCCc3ccncc3)c2)c1 InChI=1S/C24H23ClN6/c25-20-5-3-6-21(13-20)30-24-17-28-16-23(31-24)19-12-22(15-27-14-19)29-9-2-1-4-18-7-10-26-11-8-18/h3,5-8,10-17,29H,1-2,4,9H2,(H,30,31) BQEIJKOXORSBIM-UHFFFAOYSA-N 6412 N-(3-chlorophenyl)-6-(5-{[4-(pyridin-4-yl)butyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[4-(4-pyridinyl)butyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 55 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens 10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6412&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330383 8036004 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10546 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3ccccc3)c2)c1 InChI=1S/C24H22ClN5/c25-20-9-4-10-21(13-20)29-24-17-27-16-23(30-24)19-12-22(15-26-14-19)28-11-5-8-18-6-2-1-3-7-18/h1-4,6-7,9-10,12-17,28H,5,8,11H2,(H,29,30) NNTGNPPBTNKLPC-UHFFFAOYSA-N 6413 N-(3-chlorophenyl)-6-{5-[(3-phenylpropyl)amino]pyridin-3-yl}pyrazin-2-amine::(3-Chloro-phenyl)-{6-[5-(3-phenyl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 59 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6413&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330384 8036005 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10547 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCOc3ccccc3)c2)c1 InChI=1S/C23H20ClN5O/c24-18-5-4-6-19(12-18)28-23-16-26-15-22(29-23)17-11-20(14-25-13-17)27-9-10-30-21-7-2-1-3-8-21/h1-8,11-16,27H,9-10H2,(H,28,29) GNKGBKAHMOQPNP-UHFFFAOYSA-N 6414 (3-Chloro-phenyl)-{6-[5-(2-phenoxy-ethylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::N-(3-chlorophenyl)-6-{5-[(2-phenoxyethyl)amino]pyridin-3-yl}pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 60 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6414&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330385 8036006 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10548 OC(=O)CCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c20-14-3-1-4-15(8-14)24-18-12-22-11-17(25-18)13-7-16(10-21-9-13)23-6-2-5-19(26)27/h1,3-4,7-12,23H,2,5-6H2,(H,24,25)(H,26,27) UVRBDUNZSLJHHW-UHFFFAOYSA-N 6415 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butanoic acid::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butyric acid::Pyrazine-Pyridine Biheteroaryl 61 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens 5220 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6415&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330386 8036007 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10549 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCNCC3)c2)c1 InChI=1S/C22H26ClN7/c23-18-3-1-4-19(12-18)28-22-16-26-15-21(29-22)17-11-20(14-25-13-17)27-5-2-8-30-9-6-24-7-10-30/h1,3-4,11-16,24,27H,2,5-10H2,(H,28,29) DERTUZZNGDWMOY-UHFFFAOYSA-N 6407 N-(3-Chlorophenyl)-6-[5-[[3-(1-piperazinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(piperazin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 50 Vascular endothelial growth factor receptor 2 Rattus norvegicus 236 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6407 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6407&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330378 8035999 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10550 CN1CCN(CCCNc2cncc(c2)-c2cncc(Nc3cccc(Cl)c3)n2)CC1 InChI=1S/C23H28ClN7/c1-30-8-10-31(11-9-30)7-3-6-27-21-12-18(14-25-15-21)22-16-26-17-23(29-22)28-20-5-2-4-19(24)13-20/h2,4-5,12-17,27H,3,6-11H2,1H3,(H,28,29) MRWZXJLKVRBEII-UHFFFAOYSA-N 6408 N-(3-chlorophenyl)-6-(5-{[3-(4-methylpiperazin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::(3-Chlorophenyl)-(6-{5-[3-(4-methyl-piperazin-1-yl)-propylamino]-pyridin-3-yl}-pyrazin-2-yl)-amine::Pyrazine-Pyridine Biheteroaryl 51 Vascular endothelial growth factor receptor 2 Rattus norvegicus 123 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6408&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330379 8036000 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10551 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCOCC3)c2)c1 InChI=1S/C22H25ClN6O/c23-18-3-1-4-19(12-18)27-22-16-25-15-21(28-22)17-11-20(14-24-13-17)26-5-2-6-29-7-9-30-10-8-29/h1,3-4,11-16,26H,2,5-10H2,(H,27,28) ILIYEHQBHWMGTJ-UHFFFAOYSA-N 6409 N-[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]-4-morpholinepropanamine::N-(3-chlorophenyl)-6-(5-{[3-(morpholin-4-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 52 Vascular endothelial growth factor receptor 2 Rattus norvegicus 180 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6409&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330380 8036001 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10552 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCN3CCCCC3)c2)c1 InChI=1S/C23H27ClN6/c24-19-6-4-7-20(13-19)28-23-17-26-16-22(29-23)18-12-21(15-25-14-18)27-8-5-11-30-9-2-1-3-10-30/h4,6-7,12-17,27H,1-3,5,8-11H2,(H,28,29) SQOMHHDPYUXRBG-UHFFFAOYSA-N 6410 (3-Chlorophenyl)-{6-[5-(3-piperidin-1-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::N-(3-chlorophenyl)-6-(5-{[3-(piperidin-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 53 Vascular endothelial growth factor receptor 2 Rattus norvegicus 399 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6410 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6410&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330381 8036002 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10553 Clc1cccc(Nc2cncc(n2)-c2cncc(NCC3CCOCC3)c2)c1 InChI=1S/C21H22ClN5O/c22-17-2-1-3-18(9-17)26-21-14-24-13-20(27-21)16-8-19(12-23-11-16)25-10-15-4-6-28-7-5-15/h1-3,8-9,11-15,25H,4-7,10H2,(H,26,27) ALEMXOWDMCVYMB-UHFFFAOYSA-N 6411 N-(3-chlorophenyl)-6-{5-[(oxan-4-ylmethyl)amino]pyridin-3-yl}pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[(tetrahydro-2H-pyran-4-yl)-methyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 54 Vascular endothelial growth factor receptor 2 Rattus norvegicus 391 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6411&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330382 8036003 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10554 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCCc3ccncc3)c2)c1 InChI=1S/C24H23ClN6/c25-20-5-3-6-21(13-20)30-24-17-28-16-23(31-24)19-12-22(15-27-14-19)29-9-2-1-4-18-7-10-26-11-8-18/h3,5-8,10-17,29H,1-2,4,9H2,(H,30,31) BQEIJKOXORSBIM-UHFFFAOYSA-N 6412 N-(3-chlorophenyl)-6-(5-{[4-(pyridin-4-yl)butyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[4-(4-pyridinyl)butyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 55 Vascular endothelial growth factor receptor 2 Rattus norvegicus 266 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6412&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330383 8036004 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10555 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3ccccc3)c2)c1 InChI=1S/C24H22ClN5/c25-20-9-4-10-21(13-20)29-24-17-27-16-23(30-24)19-12-22(15-26-14-19)28-11-5-8-18-6-2-1-3-7-18/h1-4,6-7,9-10,12-17,28H,5,8,11H2,(H,29,30) NNTGNPPBTNKLPC-UHFFFAOYSA-N 6413 N-(3-chlorophenyl)-6-{5-[(3-phenylpropyl)amino]pyridin-3-yl}pyrazin-2-amine::(3-Chloro-phenyl)-{6-[5-(3-phenyl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::Pyrazine-Pyridine Biheteroaryl 59 Vascular endothelial growth factor receptor 2 Rattus norvegicus 2277 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6413&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330384 8036005 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10556 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCOc3ccccc3)c2)c1 InChI=1S/C23H20ClN5O/c24-18-5-4-6-19(12-18)28-23-16-26-15-22(29-23)17-11-20(14-25-13-17)27-9-10-30-21-7-2-1-3-8-21/h1-8,11-16,27H,9-10H2,(H,28,29) GNKGBKAHMOQPNP-UHFFFAOYSA-N 6414 (3-Chloro-phenyl)-{6-[5-(2-phenoxy-ethylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine::N-(3-chlorophenyl)-6-{5-[(2-phenoxyethyl)amino]pyridin-3-yl}pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 60 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6414&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330385 8036006 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10557 OC(=O)CCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H18ClN5O2/c20-14-3-1-4-15(8-14)24-18-12-22-11-17(25-18)13-7-16(10-21-9-13)23-6-2-5-19(26)27/h1,3-4,7-12,23H,2,5-6H2,(H,24,25)(H,26,27) UVRBDUNZSLJHHW-UHFFFAOYSA-N 6415 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butanoic acid::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butyric acid::Pyrazine-Pyridine Biheteroaryl 61 Vascular endothelial growth factor receptor 2 Rattus norvegicus 568 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6415&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330386 8036007 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10558 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10559 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10560 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10561 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10562 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cccn3)c2)c1 InChI=1S/C21H20ClN7/c22-17-4-1-5-18(11-17)27-21-15-24-14-20(28-21)16-10-19(13-23-12-16)25-6-2-8-29-9-3-7-26-29/h1,3-5,7,9-15,25H,2,6,8H2,(H,27,28) YHWHYCTUDCULTF-UHFFFAOYSA-N 6420 N-(3-Chlorophenyl)-6-[5-[[3-(1H-pyrazol-1-yl)propyl]-amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(1H-pyrazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 57 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6420&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330391 8036012 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10563 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cncn3)c2)c1 InChI=1S/C20H19ClN8/c21-16-3-1-4-17(8-16)27-20-12-23-11-19(28-20)15-7-18(10-22-9-15)25-5-2-6-29-14-24-13-26-29/h1,3-4,7-14,25H,2,5-6H2,(H,27,28) QGAMKOCDVQJIEP-UHFFFAOYSA-N 6421 N-(3-chlorophenyl)-6-(5-{[3-(1H-1,2,4-triazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(1H-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 58 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6421&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330392 8036013 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10564 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCC(=O)N3CCCCC3)c2)c1 InChI=1S/C24H27ClN6O/c25-19-6-4-7-20(13-19)29-23-17-27-16-22(30-23)18-12-21(15-26-14-18)28-9-5-8-24(32)31-10-2-1-3-11-31/h4,6-7,12-17,28H,1-3,5,8-11H2,(H,29,30) XHUDKIDUXNJFIC-UHFFFAOYSA-N 6422 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]-1-(piperidin-1-yl)butan-1-one::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-1-piperidin-1-yl-butan-1-one::Pyrazine-Pyridine Biheteroaryl 62 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6422&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330393 8036014 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10565 OCCCNc1cnc(F)c(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H17ClFN5O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H,24,25) CWLYLDIPBOBIFQ-UHFFFAOYSA-N 6423 3-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-6-fluoropyridin-3-ylamino}-propan-1-ol::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-6-fluoropyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 70 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6423&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330394 8036015 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10566 OCCCNc1cnc(Cl)c(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H17Cl2N5O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H,24,25) CWSMCLMKHVQLFW-UHFFFAOYSA-N 6424 3-[(6-chloro-5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-{6-Chloro-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 76 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6424&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330395 8036016 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10567 Nc1ncc(NCCCO)cc1-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H19ClN6O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H2,20,23)(H,24,25) HWMHBHCITCJTIA-UHFFFAOYSA-N 6425 3-[(6-amino-5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-{6-Amino-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 79 Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1 Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=95&target=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6425&enzyme=Cyclin-dependent+kinase%2FG2%2Fmitotic-specific+cyclin-+1&column=ki&startPg=0&Increment=50&submit=Search 5330396 8036017 2 MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM 7NJ0,4YC6,6GU7,6GU6,6GU4,6GU3,6GU2,5LQF,5HQ0,4YC3,4Y72 Cyclin-dependent kinase 1 CDK1_HUMAN P06493 A8K7C4 C9J497 O60764 MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV 7NJ0,2JGZ,9FH9 G2/mitotic-specific cyclin-B1 CCNB1_HUMAN P14635 A8K066 Q5TZP9 10568 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Vascular endothelial growth factor receptor 2 Rattus norvegicus 84 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10569 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Vascular endothelial growth factor receptor 2 Rattus norvegicus 63 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10570 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Vascular endothelial growth factor receptor 2 Rattus norvegicus 105 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10571 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Vascular endothelial growth factor receptor 2 Rattus norvegicus 76 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10572 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cccn3)c2)c1 InChI=1S/C21H20ClN7/c22-17-4-1-5-18(11-17)27-21-15-24-14-20(28-21)16-10-19(13-23-12-16)25-6-2-8-29-9-3-7-26-29/h1,3-5,7,9-15,25H,2,6,8H2,(H,27,28) YHWHYCTUDCULTF-UHFFFAOYSA-N 6420 N-(3-Chlorophenyl)-6-[5-[[3-(1H-pyrazol-1-yl)propyl]-amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(1H-pyrazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 57 Vascular endothelial growth factor receptor 2 Rattus norvegicus 94 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6420&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330391 8036012 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10573 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cncn3)c2)c1 InChI=1S/C20H19ClN8/c21-16-3-1-4-17(8-16)27-20-12-23-11-19(28-20)15-7-18(10-22-9-15)25-5-2-6-29-14-24-13-26-29/h1,3-4,7-14,25H,2,5-6H2,(H,27,28) QGAMKOCDVQJIEP-UHFFFAOYSA-N 6421 N-(3-chlorophenyl)-6-(5-{[3-(1H-1,2,4-triazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(1H-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 58 Vascular endothelial growth factor receptor 2 Rattus norvegicus 67 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6421&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330392 8036013 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10574 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCC(=O)N3CCCCC3)c2)c1 InChI=1S/C24H27ClN6O/c25-19-6-4-7-20(13-19)29-23-17-27-16-22(30-23)18-12-21(15-26-14-18)28-9-5-8-24(32)31-10-2-1-3-11-31/h4,6-7,12-17,28H,1-3,5,8-11H2,(H,29,30) XHUDKIDUXNJFIC-UHFFFAOYSA-N 6422 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]-1-(piperidin-1-yl)butan-1-one::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-1-piperidin-1-yl-butan-1-one::Pyrazine-Pyridine Biheteroaryl 62 Vascular endothelial growth factor receptor 2 Rattus norvegicus 610 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6422&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330393 8036014 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10575 OCCCNc1cnc(F)c(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H17ClFN5O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H,24,25) CWLYLDIPBOBIFQ-UHFFFAOYSA-N 6423 3-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-6-fluoropyridin-3-ylamino}-propan-1-ol::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}-6-fluoropyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 70 Vascular endothelial growth factor receptor 2 Rattus norvegicus 251 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6423&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330394 8036015 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10576 OCCCNc1cnc(Cl)c(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H17Cl2N5O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H,24,25) CWSMCLMKHVQLFW-UHFFFAOYSA-N 6424 3-[(6-chloro-5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-{6-Chloro-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 76 Vascular endothelial growth factor receptor 2 Rattus norvegicus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6424&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330395 8036016 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10577 Nc1ncc(NCCCO)cc1-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H19ClN6O/c19-12-3-1-4-13(7-12)24-17-11-21-10-16(25-17)15-8-14(9-23-18(15)20)22-5-2-6-26/h1,3-4,7-11,22,26H,2,5-6H2,(H2,20,23)(H,24,25) HWMHBHCITCJTIA-UHFFFAOYSA-N 6425 3-[(6-amino-5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::3-{6-Amino-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::Pyrazine-Pyridine Biheteroaryl 79 Vascular endothelial growth factor receptor 2 Rattus norvegicus 1360 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=851&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6425&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330396 8036017 1 mesrallavalwfcvetraasvglpgdslhppklstqkdiltilanttlqitcrgqrdldwlwpntprdseervlvtecgdsifcktltvprvvgndtgaykcfyrdtdvssivyvyvqdhrspfiasvsdehgivyitenknktvvipcrgsisnlnvslcarypekrfvpdgnriswdsekgftipsymisyagmvfceakindetyqsimyivlvvgyriydvvlsppheielsageklvlnctartelnvgldfswqfpsskhqhkkivnrdvkslpgtvakmflstltidsvtksdqgeytctaysglmtkknktfvrvhtkpfiafgsgmkslveatvgsqvripvkylsypapdikwyrngrpiesnytmivgdeltimevserdagnytviltnpismekqshmvslvvnvppqigekalispmdsyqygtmqtltctvyanpplhhiqwywqleeacsyrpsqtnpytckewrhvkdfqggnkievtknqyaliegknktvstlviqaayvsalykceainkagrgervisfhvirgpeitvqpatqpteresmsllctadrntfenltwyklgsqatsvhmgesltpvcknldalwklngtvfsnstndilivafqnaslqdqgnyvcsaqdkktkkrhclvkqlvilermapmitgnlenqtttigetievvcptsgnptplitwfkdnetlvedsgivlkdgnrnltirrvrkedgglytcqacnvlgcaraetlfiiegvqektnleviilvgtaviamffwlllvilvrtvkranegelktgylsivmdpdelpldercerlpydaskwefprdrlklgkplgrgafgqvieadafgidktatcktvavkmlkegathsehralmselkilihighhlnvvnllgactkpggplmvivefckfgnlstylrgkrnefvpykskgarfrsgkdyvgelsvdlkrrldsitssqssassgfveekslsdveeeeaseelykdfltlehlicysfqvakgmeflasrkcihrdlaarnillseknvvkicdfglardiykdpdyvrkgdprlplkwmapetifdriytiqsgvwsfgvllweifslgaspypgvkidekfcrrlkegtrmrapdyttpemyqtmldcwhedpnqrpafselvehlgnllqanaqqdgkdyivlpmsetlsmeedsglslptspvscmeeeevcdpkfhydntagishylqnskrksrpvsvktfedipleepevkvipddsqtdsgmvlaseelktledrnklspsfggmmpsksresvasegsnqtsgyqsgyhsddtdttvyssdeagllklvdvaghvdsgttlrsspv Vascular endothelial growth factor receptor 2 VGFR2_RAT O08775 10608 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Platelet-derived growth factor receptor beta Homo sapiens 360 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10609 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Platelet-derived growth factor receptor beta Homo sapiens 2800 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10610 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Platelet-derived growth factor receptor beta Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10611 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Platelet-derived growth factor receptor beta Homo sapiens 876 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10612 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cccn3)c2)c1 InChI=1S/C21H20ClN7/c22-17-4-1-5-18(11-17)27-21-15-24-14-20(28-21)16-10-19(13-23-12-16)25-6-2-8-29-9-3-7-26-29/h1,3-5,7,9-15,25H,2,6,8H2,(H,27,28) YHWHYCTUDCULTF-UHFFFAOYSA-N 6420 N-(3-Chlorophenyl)-6-[5-[[3-(1H-pyrazol-1-yl)propyl]-amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(1H-pyrazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 57 Platelet-derived growth factor receptor beta Homo sapiens 1700 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6420&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330391 8036012 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10613 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cncn3)c2)c1 InChI=1S/C20H19ClN8/c21-16-3-1-4-17(8-16)27-20-12-23-11-19(28-20)15-7-18(10-22-9-15)25-5-2-6-29-14-24-13-26-29/h1,3-4,7-14,25H,2,5-6H2,(H,27,28) QGAMKOCDVQJIEP-UHFFFAOYSA-N 6421 N-(3-chlorophenyl)-6-(5-{[3-(1H-1,2,4-triazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(1H-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 58 Platelet-derived growth factor receptor beta Homo sapiens 725 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=575&target=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6421&enzyme=Platelet-derived+growth+factor+receptor+beta&column=ki&startPg=0&Increment=50&submit=Search 5330392 8036013 1 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 3MJG Platelet-derived growth factor receptor beta PGFRB_HUMAN P09619 B5A957 Q8N5L4 10614 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus 478 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10615 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus 4020 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10616 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10617 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus 318 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10618 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cccn3)c2)c1 InChI=1S/C21H20ClN7/c22-17-4-1-5-18(11-17)27-21-15-24-14-20(28-21)16-10-19(13-23-12-16)25-6-2-8-29-9-3-7-26-29/h1,3-5,7,9-15,25H,2,6,8H2,(H,27,28) YHWHYCTUDCULTF-UHFFFAOYSA-N 6420 N-(3-Chlorophenyl)-6-[5-[[3-(1H-pyrazol-1-yl)propyl]-amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(1H-pyrazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 57 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus 606 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6420&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330391 8036012 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10619 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cncn3)c2)c1 InChI=1S/C20H19ClN8/c21-16-3-1-4-17(8-16)27-20-12-23-11-19(28-20)15-7-18(10-22-9-15)25-5-2-6-29-14-24-13-26-29/h1,3-4,7-14,25H,2,5-6H2,(H,27,28) QGAMKOCDVQJIEP-UHFFFAOYSA-N 6421 N-(3-chlorophenyl)-6-(5-{[3-(1H-1,2,4-triazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(1H-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 58 Glycogen synthase kinase-3 beta [7-25] Oryctolagus cuniculus 196 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=862&target=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6421&enzyme=Glycogen+synthase+kinase-3+beta+%5B7-25%5D&column=ki&startPg=0&Increment=50&submit=Search 5330392 8036013 1 TTSFAESCKPVQQPSAFGS Glycogen synthase kinase-3 beta G1T8E2_RABIT G1T8E2 10620 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Fibroblast growth factor receptor 2 Homo sapiens 210 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10621 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Fibroblast growth factor receptor 2 Homo sapiens 2360 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10622 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Fibroblast growth factor receptor 2 Homo sapiens 1400 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10623 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Fibroblast growth factor receptor 2 Homo sapiens 293 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10624 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cccn3)c2)c1 InChI=1S/C21H20ClN7/c22-17-4-1-5-18(11-17)27-21-15-24-14-20(28-21)16-10-19(13-23-12-16)25-6-2-8-29-9-3-7-26-29/h1,3-5,7,9-15,25H,2,6,8H2,(H,27,28) YHWHYCTUDCULTF-UHFFFAOYSA-N 6420 N-(3-Chlorophenyl)-6-[5-[[3-(1H-pyrazol-1-yl)propyl]-amino]-3-pyridinyl]-2-pyrazinamine::N-(3-chlorophenyl)-6-(5-{[3-(1H-pyrazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 57 Fibroblast growth factor receptor 2 Homo sapiens 326 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6420&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330391 8036012 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10625 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCn3cncn3)c2)c1 InChI=1S/C20H19ClN8/c21-16-3-1-4-17(8-16)27-20-12-23-11-19(28-20)15-7-18(10-22-9-15)25-5-2-6-29-14-24-13-26-29/h1,3-4,7-14,25H,2,5-6H2,(H,27,28) QGAMKOCDVQJIEP-UHFFFAOYSA-N 6421 N-(3-chlorophenyl)-6-(5-{[3-(1H-1,2,4-triazol-1-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(1H-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 58 Fibroblast growth factor receptor 2 Homo sapiens 153 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=856&target=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6421&enzyme=Fibroblast+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 5330392 8036013 1 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT 2PSQ,1OEC,1GJO,8STG,5EG3,6LVL,6LVK,8H75,7OZY,8YKI,1EV2,1E0O,1DJS Fibroblast growth factor receptor 2 FGFR2_HUMAN P21802 B4DFC2 E7EVR6 E9PCR0 P18443 Q01742 Q12922 Q14300 Q14301 Q14302 Q14303 Q14304 Q14305 Q14672 Q14718 Q14719 Q1KHY5 Q86YI4 Q8IXC7 Q96KL9 Q96KM0 Q96KM1 Q96KM2 Q9NZU2 Q9NZU3 Q9UD01 Q9UD02 Q9UIH3 Q9UIH4 Q9UIH5 Q9UIH6 Q9UIH7 Q9UIH8 Q9UM87 Q9UMC6 Q9UNS7 Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0 10626 OCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(8-14)23-18-12-21-11-17(24-18)13-7-16(10-20-9-13)22-5-2-6-25/h1,3-4,7-12,22,25H,2,5-6H2,(H,23,24) UCHQCSDTPQKAKL-UHFFFAOYSA-N 6416 3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol::Pyrazine-Pyridine deriv. 15::3-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]propan-1-ol::Pyrazine-Pyridine Biheteroaryl 7 Epidermal growth factor receptor Homo sapiens 1360 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6416&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 5330387 8036008 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9H46,9GL9,9GI9,9FRD,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,7ZYP,7ZYN,7ZYM,6S8A,6S89,8A2A,8A27,8HY7,8HV5,8HV3,8HV1,7OXB,5Y25,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5 Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 10627 OCCCCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H20ClN5O/c20-15-4-3-5-16(9-15)24-19-13-22-12-18(25-19)14-8-17(11-21-10-14)23-6-1-2-7-26/h3-5,8-13,23,26H,1-2,6-7H2,(H,24,25) IDNNHUIRPPFJBA-UHFFFAOYSA-N 6417 4-[(5-{6-[(3-chlorophenyl)amino]pyrazin-2-yl}pyridin-3-yl)amino]butan-1-ol::4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol::Pyrazine-Pyridine Biheteroaryl 39 Epidermal growth factor receptor Homo sapiens 7400 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6417&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 5330388 8036009 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9H46,9GL9,9GI9,9FRD,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,7ZYP,7ZYN,7ZYM,6S8A,6S89,8A2A,8A27,8HY7,8HV5,8HV3,8HV1,7OXB,5Y25,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5 Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 10628 CN(C)CCNc1cncc(c1)-c1cncc(Nc2cccc(Cl)c2)n1 InChI=1S/C19H21ClN6/c1-26(2)7-6-23-17-8-14(10-21-11-17)18-12-22-13-19(25-18)24-16-5-3-4-15(20)9-16/h3-5,8-13,23H,6-7H2,1-2H3,(H,24,25) XTEWWTLBXKFYCF-UHFFFAOYSA-N 6418 N-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N ,N -dimethyl-ethane-1,2-diamine::N-(3-chlorophenyl)-6-(5-{[2-(dimethylamino)ethyl]amino}pyridin-3-yl)pyrazin-2-amine::Pyrazine-Pyridine Biheteroaryl 41 Epidermal growth factor receptor Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6418&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 5330389 8036010 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9H46,9GL9,9GI9,9FRD,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,7ZYP,7ZYN,7ZYM,6S8A,6S89,8A2A,8A27,8HY7,8HV5,8HV3,8HV1,7OXB,5Y25,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5 Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 10629 Clc1cccc(Nc2cncc(n2)-c2cncc(NCCCc3cccnc3)c2)c1 InChI=1S/C23H21ClN6/c24-19-6-1-7-20(11-19)29-23-16-27-15-22(30-23)18-10-21(14-26-13-18)28-9-3-5-17-4-2-8-25-12-17/h1-2,4,6-8,10-16,28H,3,5,9H2,(H,29,30) IRNVMUQZQDLZAK-UHFFFAOYSA-N 6419 N-(3-chlorophenyl)-6-(5-{[3-(pyridin-3-yl)propyl]amino}pyridin-3-yl)pyrazin-2-amine::N-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine::Pyrazine-Pyridine Biheteroaryl 56 Epidermal growth factor receptor Homo sapiens >10000 Curated from the literature by BindingDB 10.1021/jm058205b 10.7270/Q2NC5ZD5 16033269 aid1795895 Kuo, GH; Prouty, C; Wang, A; Emanuel, S; Deangelis, A; Zhang, Y; Song, F; Beall, L; Connolly, PJ; Karnachi, P; Chen, X; Gruninger, RH; Sechler, J; Fuentes-Pesquera, A; Middleton, SA; Jolliffe, L; Murray, WV 7/28/2005 11/7/2005 Johnson & Johnson Pharmaceutical http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=6419&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 5330390 8036011 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9H46,9GL9,9GI9,9FRD,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,7ZYP,7ZYN,7ZYM,6S8A,6S89,8A2A,8A27,8HY7,8HV5,8HV3,8HV1,7OXB,5Y25,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5 Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5